HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health Canada clarifies labeling regs

This article was originally published in The Rose Sheet

Executive Summary

Cosmetic products with "small, ornamental, non-existent or odd packaging" are addressed in agency's 1clarification of labeling requirements under Canada's Food and Drugs Act. Health department says firms marketing products housed in containers or outside packages so small that they cannot comply with regulations - such as eyeliner pencils, lipsticks or nail enamel - can affix a list of ingredients on a tag, tape or card. It notes that "ingredient list tear-away pads at point of sale, such as those used in the United States for these types of cosmetics," are not accepted for such items under Canadian law. An ingredient list similarly may be affixed to a product container bearing no promotional or advertising material other than a trade-name that "is sold as a decorative ornament in addition to being sold as the container of a cosmetic." A perfume bottle or key chain bauble that contains a lip balm might qualify as such, according to April document. In the case that a container's odd size, shape or texture makes it impractical to attach a tag, tape or card, an ingredient tear-away pad, leaflet or sign can be used "at the point where exposed for sale.

You may also be interested in...

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 

Stockwatch: Choppy Waters For Teva And Bausch

After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.



Big Data Offers International Benefits

The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts